It is also Non-GMO and Kosher
The product also includes a complete B-vitamin complex and electrolytes from sodium and potassium citrate, making it a well-rounded pre-workout option
For example, over two years, total costs averaged ~$51,794 for surgical patients vs ~$63,483 for GLP-1 therapy
[41] Huang M, Liu Y, Ramji D, et al
At Refine by Tulsi, Dr Kotecha has been working with numerous patients to develop a personalized, science-backed weaning protocols to help patients maintain their weight loss while gradually reducing reliance and cost associated with GLP-1s
In June 2025, Eli Lilly reported Phase III ACHIEVE-1 Survodutide (BI 456906): Boehringer Ingelhium Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium